Deepak Nitrite Subsidiary Allots ₹120 Crore OCRPS to Another Subsidiary
Deepak Nitrite Limited announced that its subsidiary, Deepak Chem Tech Limited, allotted ₹120 Crore worth of 9% Optionally Convertible Redeemable Preference Shares to another wholly-owned subsidiary, Deepak Phenotics Limited. This infusion aims to bolster DCTL's capital base for project expenses and general corporate needs.
This is an internal restructuring and fund allocation between wholly-owned subsidiaries, not involving external parties or significant new investments that would materially impact the company's financial performance or market dynamics.
The transaction is an internal fund reallocation between subsidiaries and does not represent a significant external business development or financial event that would impact the company's overall market position or profitability.
Deepak Chem Tech Limited (DCTL), a wholly-owned subsidiary of Deepak Nitrite Limited, has issued and allotted 1,20,00,000 9% Optionally Convertible Redeemable Preference Shares (OCRPS) with a face value of ₹100 each, aggregating to ₹120.00 Crores to Deepak Phenotics Limited (DPL), another wholly-owned subsidiary.
The infusion of funds into DCTL by DPL is intended to strengthen DCTL's capital base and support its project expenses and general corporate purposes. DCTL is involved in fluorination, nitric acid, nitration, and hydrogenation, with ongoing projects in Gujarat. The turnover of DCTL during FY2025-26 was ₹172.23 Crores.
The transaction, which took place on May 30, 2026, is considered a Related Party Transaction (RPT) as both DCTL and DPL are wholly-owned subsidiaries. The allotment was made at par, meaning at ₹100 per share, on an "arms length" basis. No governmental or regulatory approvals were required for this investment. Post-allotment, Deepak Nitrite Limited continues to hold 100% of DCTL's equity share capital and indirectly holds 100% of its preference share capital along with DPL.
What to do with a filing like this
Deepak Nitrite Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Deepak Nitrite Limited. Read the original for the full detail.